Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric electrical activity (GEA) refers to the rhythmic, spontaneous myogenic depolarizations and repolarizations that occur within the smooth muscle of the stomach, driven by specialized cells called Interstitial Cells of Cajal (ICCs) (Sanders et al., 2014; PubMed: 24961819). These electrical events, primarily slow waves, propagate from the gastric pacemaker area toward the pylorus to coordinate the frequency, velocity, and direction of peristaltic contractions (O'Grady et al., 2010; PubMed: 20146310). Distortions in these rhythms, termed gastric dysrhythmias (including tachygastria and bradygastria), are central to the pathophysiology of gastrointestinal motility disorders such as gastroparesis and chronic functional dyspepsia (Parkman et al., 2003; PubMed: 12630788). While GEA is a physiological phenomenon rather than a single molecular target, it is clinically modulated via Gastric Electrical Stimulation (GES) devices to treat refractory nausea and vomiting (Soffer et al., 2008; PubMed: 18193021). Pharmacological agents such as prokinetics indirectly influence GEA by targeting receptors like 5-HT4, D2, or motilin, which are involved in the neuro-muscular signaling of the gastric wall (Gershon and Tack, 2007; PubMed: 17126188). Consequently, GEA serves as a critical diagnostic and therapeutic endpoint in gastroenterology, monitored through techniques like electrogastrography (EGG) (Yin and Chen, 2013; PubMed: 23626244).
Modulation of gastric electrical activity is achieved via Gastric Electrical Stimulation (GES) using implantable electrodes or pharmacologically through prokinetic agents that target 5-HT4, D2, or motilin receptors to enhance neuromuscular signaling and coordinate slow-wave propagation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric electrical activity (GEA).